Relevium To Host Screenings of Documentary “Weed The People” Across Canada Today


Tony Deyes

January 15th, 2019

Exclusive, Top News


Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) will host the screening of “Weed the People” in eight Canadian cities on Tuesday, January 15, 2019.

In partnership with Executive Producer Ricki Lake, Director Abby Epstein, and Cannakids.org, Relevium will host a nation-wide screening of this compelling, emotional, and educational film that explores the potential benefits of medical cannabis oils for pediatric applications, followed by live discussions.

The film follows the journey of five families with children battling cancer, and the introduction of cannabis oil into their treatment after the failure of conventional methods. The families profiled pursue the use of cannabis alongside conventional treatments, including chemotherapy and radiation, revealing thought-provoking outcomes that support the need for research, and exposing the legal hurdles faced by families pursuing lifesaving alternatives for their children.

“The film is an amazing journey into the potential opportunities of complementing traditional treatments for cancer and other illness in pediatric patients,” said Aurelio Useche, CEO of Relevium Technologies. “We at Relevium are committed to introduce and further develop these possibilities, which is why we feel everyone should attend the screening of this amazing documentary, a film that not only opens a potential door for hope for patients and their families, but also further validates the legalization of cannabis in Canada.”

Montreal-based CannaKids’ research and product development centres primarily around pediatric applications, but also services patients of all ages, and through its database of thousands of patients, CannaKids leverages a network of trained nursing staff, pediatric and adult dosing experts, medical doctors, and leading researchers in Canada, the US, and Israel.

Tracy Ryan, the CEO of CK Properties and its brand Cannakids, and her family are one of the five families described in the film, which also examines her motivation to enter into the medical cannabis business to support her daughter’s battle against cancer.

Relevium Technologies recently announced the exclusive license from Cannakids to introduce medical cannabis formulations, SOPs, and branding into the Canadian market to pursue pediatric applications and support ongoing research.

Relevium will leverage CannaKids’ existing infrastructure and standard operating procedures to launch the brand across Canada and to expand its existing patient network to support ongoing research for cancer as well as autism, epilepsy, and other specialized applications. Relevium and CannaKids will partner their combined medical cannabis and nutraceutical formulation expertise to co-develop new products and delivery mechanisms for the US and Canadian Markets.

Abby Epstein is a film director and producer, who prior to her film work, directed award-winning theatre productions of RENT and “The Vagina Monologues.”

Ricki Lake is an American film actress and television host best known for her starring role in the original movie “Hairspray” and for her daytime talk show, “The Ricki Lake Show” which aired for 11 seasons until 2005, and returned in 2012, resulting in an Emmy win.

Abby Epstein and Ricki Lake have produced and directed ground-breaking documentaries including “The Business of Being Born”, “Sweetening the Pill”, “The Mama Sherpas” and now “Weed the People”.

For further information and to obtain tickets:

Tel: +1.888.528.8687 RELEVIUM TECHNOLOGIES INC

Email: [email protected]

Website: www.releviumtechnologies.com

 

 

 

 

Disclaimer

The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/

Avatar

About Tony Deyes



Network Partners

Follow Us on Social Media

About CFN Media

CFN Media (CannabisFN) is the leading creative agency and media network dedicated to legal cannabis. We help marijuana businesses attract investors, customers (B2B, B2C), capital, and media visibility. Private and public marijuana companies and brands in the US and Canada rely on CFN Media to grow and succeed.

CFN launched in June of 2013 to initially serve the growing universe of publicly traded marijuana companies across North America. Today, CFN Media is also the digital media choice for the emerging brands in the space.

Learn How Your Company can Be Covered on CFN Media

Learn More About the CFN Media Sponsored Content Program

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © TDM Financial LLC · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading